Publication Name	World Journal of Methodology
Manuscript ID	30770
Country	Cyprus

Received	2016-10-19 10:39
Peer-Review Started	2016-10-19 16:14
To Make the First Decision	2016-11-30 08:54
Return for Revision	2016-11-30 14:19
Revised	2016-12-15 00:00
Second Decision	2016-12-20 15:49
Accepted by Journal Editor-in-Chief	2016-12-21 01:00
Accepted by Executive Editor-in-Chief	2017-01-03 15:24
Articles in Press	2017-01-03 15:24
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2017-03-20 09:11
Publish the Manuscript Online	2017-03-24 10:35

ISSN	2222-0682 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2017. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Oncology
Manuscript Type	Minireviews
Article Title	Chromogranin A as a valid marker in oncology: Clinical application or false hopes?
Manuscript Source	Invited Manuscript
All Author List	Stavros Gkolfinopoulos, Konstantinos Tsapakidis, Konstantinos Papadimitriou, Demetris Papamichael and Panteleimon Kountourakis
Funding Agency and Grant Number
Corresponding Author	Panteleimon Kountourakis, MD, PhD, Department of Medical Oncology, BOC Oncology Center, 32 Acropoleos Ave, 2006 Strovolos, Nicosia, Cyprus. pantkount@gmail.com
Key Words	Cancer; Neuroendocrine tumors; Prognosis; Chromogranin A; Biomarker
Core Tip	In the era of targeted therapy, there is an unmet need for the development of more sensitive, specific and reliable biomarkers for early diagnosis, prognosis and detection of early recurrence to tumors which comprise an extremely heterogeneous group.
Publish Date	2017-03-24 10:35
Citation	Gkolfinopoulos S, Tsapakidis K, Papadimitriou K, Papamichael D, Kountourakis P. Chromogranin A as a valid marker in oncology: Clinical application or false hopes? World J Methodol 2017; 7(1): 9-15
URL	http://www.wjgnet.com/2222-0682/full/v7/i1/9.htm
DOI	http://dx.doi.org/10.5662/wjm.v7.i1.9

Full Article (PDF)	WJM-7-9.pdf
Full Article (Word)	WJM-7-9.doc
Manuscript File	30770-Review.docx
Answering Reviewers	30770-Answering reviewers.pdf
Audio Core Tip	30770-Audio core tip.mp3
Conflict-of-Interest Disclosure Form	30770-Conflict-of-interest statement.pdf
Copyright License Agreement	30770-Copyright assignment.pdf
Peer-review Report	30770-Peer-review(s).pdf
Journal Editor-in-Chief Review Report	30770-Journal editor-in-chief review report.pdf
Scientific Misconduct Check	30770-Scientific misconduct check.pdf
Scientific Editor Work List	30770-Scientific editor work list.pdf